Search Results 1881-1890 of 12798 for alcohol menopause
... alcoholic Steatohepatitis (NASH) Cirrhosis (MAESTRO-NASH OUTCOMES) A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients ...
Alcohol or drug use disorders. Tobacco use. Some prescription drugs also can cause or play a role in ED . These include certain medicines for depression and ...
Outcomes following liver transplantation for patients with alcohol versus nonalcoholic-induced liver disease. Canadian Journal of Gastroenterology. 2000 Nov ...
Use of renal function measurements for assessing fracture risk in postmenopausal women. Mayo Clin Proc. 2008 Nov; 83 (11):1231-9. View PubMed; Weenig RH ...
... Alcoholic Steatohepatitis (NASH) Cirrhosis (ENCORE-LF) Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis NCT ID ...
Beyond that, limit dairy products, eating smaller meals, stay hydrated, and try to avoid caffeine, alcohol, and carbonation. Consider multivitamins if you ...
... postmenopausal (i.e., who have not menstruated at all) for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive ...
This study is being done to look at the cardiovascular response, if any, to intake of commercially available energy drink. We hypothesize that energy drink ...
Alcohol use in excess (14 drinks or more per week for women and 21 drinks or more per week for men). Investigating the Link Between Type 2 Immunity and NAFLD ...
Title: A Randomized Phase II Trial of Tamoxifen Versus Z-Endoxifen HCL in Postmenopausal Women With Metastatic Estrogen Receptor Positive, HER2 Negative Breast ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.